METHODS AND DEVICES FOR MANIPULATING THE GLYMPHATIC SYSTEM FOR MEDICAL TREATMENTS
20230320925 · 2023-10-12
Inventors
Cpc classification
A61M16/0045
HUMAN NECESSITIES
International classification
A61M16/00
HUMAN NECESSITIES
Abstract
Methods and devices are provided for manipulating the glymphatic system to improve cognitive and other cranial or brain functions of a subject. In particular, pressure is alternately applied to the jugular veins on either side of the subject's neck to generate a to and fro movement of cranial fluids.
Claims
1. A method for improving, repairing or preventing impairment of brain function in a subject by facilitating cerebral blood and cerebral spinal fluid flow, comprising increasing blood flow away from the brain and down the spinal cord and interstitial spaces through the Glymphatic Pathways.
2. The method of claim 1, further comprising increasing one or both of the intracranial pressure and the intracranial blood volume, to increase blood flow away from the brain.
3. The method of claim 2, wherein the step of increasing one or both of the intracranial pressure and the intracranial blood volume is achieved by administering changes to inspired CO.sub.2 levels of the subject by using exogenous or endogenous CO.sub.2.
4. The method of claim 2, wherein the step of increasing one or both of the intracranial pressure and the intracranial blood volume is achieved by applying pressure to one or more neck veins.
5. The method of claim 4, wherein the one or more neck veins includes at least one internal jugular vein or at least one external jugular vein.
6. The method of claims 4, wherein pressure applied to the one or more neck veins is about 10 mm Hg to about 100 mm Hg.
7. The method of claim 4, wherein the pressure applied to one or more neck veins is applied intermittently in a plurality of cycles, wherein each cycle is characterized as having an on-time having a first neck vein pressure and an off-time having a second neck vein pressure, wherein the first neck vein pressure is greater than the second neck vein pressure.
8. The method of claim 7, wherein the on-time has a duration of one second to one hour.
9. The method of claim 7, wherein the off-time has a duration of one second to one hour.
10. The method of claim 7, wherein the first neck vein pressure is 10-100 mm Hg.
11. The method of claim 7, wherein the second neck vein pressure is 0-50 mm Hg.
12. The method of claim 7, wherein the first neck vein pressure is at least 20 mm Hg greater than the second neck vein pressure.
13. The method of claim 7, wherein each cycle has a duration of five seconds to two hours.
14. The method of claim 4, wherein the pressure applied to one or more neck veins is applied alternately to one or more veins on one side of the neck and then to one or more veins on the other side of the neck.
15. A method for improving, repairing or preventing impairment of brain function in a subject by facilitating cerebral blood and cerebral spinal fluid flow by increasing blood flow away from the brain and down the spinal cord through the Glymphatic Pathways, comprising applying pressure to one or more neck veins on each side of the subject's neck, wherein the pressure is applied alternately to one or more veins on one side of the neck and then to one or more veins on the other side of the neck.
16. The method of claim 15, wherein the pressure is applied intermittently in a plurality of cycles, wherein each cycle is characterized as having an on-time having a first neck vein pressure and an off-time having a second neck vein pressure, wherein the first neck vein pressure is greater than the second neck vein pressure.
17. The method of claim 16, wherein the on-time has a duration of one second to one hour.
18. The method of claim 16, wherein the off-time has a duration of one second to one hour.
19. The method of claim 16, wherein the first neck vein pressure is 10-100 mm Hg.
20. The method of claim 16, wherein the second neck vein pressure is 0-50 mm Hg.
21. The method of claim 16, wherein the first neck vein pressure is at least 20 mm Hg greater than the second neck vein pressure.
22. The method of claim 16, wherein each cycle has a duration of five seconds to two hours.
23. A device for applying pressure to one or more neck veins on each side of the neck of a subject, comprising: a circumferential C-shaped collar sized to partially encircle the neck of the subject; a pair of compression elements movably mounted on the collar, each compression element sized and oriented on said collar to apply pressure to one or more neck veins on each side of the neck; and a drive mechanism for moving said compression elements relative to said collar to alternately apply pressure to the one or more neck veins on each side of the neck of the subject, wherein the pressure is sufficient to restrict blood flow egressing from the head of the subject through the one or more neck veins.
24. The device of claim 23, wherein: said C-shaped collar includes opposite ends: and each of said pair of compression elements is movably mounted to a corresponding one of said opposite ends.
25. The device of claim 24, wherein each of said pair of compression elements is a lever pivotably or slidably mounted to said corresponding one of said opposite ends of said collar.
26. The device of claim 24, wherein each of said pair of compression elements is an expandable bellows structure mounted to said corresponding one of said opposite ends of said collar.
27. The device of claim 23, wherein said pair of compression elements are at opposite ends of a C-shaped compression element that is pivotably mounted to said C-shaped collar to pivot between a neutral position in which said C-shaped compression element is overlapped by said C-shaped collar, and compression positions in which one or the other of the opposite ends of said C-shaped compression element is pivoted toward the neck of the subject.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
DETAILED DESCRIPTION
[0056] The present invention provides methods and devices for improving brain functions (e.g., arousal, attention/attentiveness, executive functions, learning, memory, motor coordination, spatial awareness, and vigilance), or even physical repair of cerebral/spinal structures by altering CSF flow within the brain. CSF flow may be altered by increasing the venous pressure and/or volume within the brain or the cranium as described herein. It is understood that the CSF volume within the brain may transiently increase and/or decrease (thereby altering the CSF flow) under conditions of increased venous pressure and/or volume within the brain or the cranium.
[0057] Mild somnolence may be caused by a variety of activities or conditions including long periods of sitting or otherwise being sedentary, performing repetitive or boring (mentally unchallenging) tasks, and/or for a lack of sleep or following long periods wakefulness. It is believed that a subject experiences temporary and reversible decline in these brain functions and/or mild somnolence as the brain accumulates somnogenic substances in the uvCSF and/or the brain parenchyma, particularly in the cortical regions. The reduction in higher brain functioning and/or mild somnolence often precedes drowsiness and sleep. Somnogenic substances believed to accumulate in the uvCSF include, for example, various cytokines, prostaglandins including prostaglandin D(2), adenosine, and others. Thus, brain function may be improved by displacing or removing the somnogenic substances from within the brain parenchyma and/or the uvCSF.
[0058] It is believed that somnogenic substances are in a rapid equilibrium between the brain parenchyma and the uvCSF. Thus, parenchymal concentrations of somnogenic substances may be rapidly reduced by reducing the uvCSF concentration of those substances. This may be achieved by altering the flow of CSF within the ventricular system including by: (i) reducing the uvCSF volume, thereby reducing the total amount of somnogenic substances present within the brain; and/or (ii) mixing the uvCSF with 1vCSF. It is believed that the 1vCSF does not accumulate somnogenic substances to the same extent as the uvCSF during somnolence. Mixing 1vCSF with uvCSF would effectively dilute the concentration of somnogenic substances within the uvCSF causing a concomitant reduction in the parenchymal somnogenic substance concentration.
[0059] CSF flow may be beneficially altered within the brain by increasing the venous pressure and/or blood volume within the brain and/or cranium. This may be achieved by partially or completely impeding blood flow through one or more cranial neck veins including, for example, the internal jugular veins and/or external jugular veins. It is believed that partial or total occlusion of one, two, three, or four of the jugular veins causes a redirection of venous blood flow into the vertebral vein(s) and venous capacitance veins while filling the cranial reserve volume and thereby increasing the blood volume and/or blood pressure within the brain. It is believed that the cranial reserve volume is filled within about <1 second to about 3 seconds, or the time taken for about 1-5 heart beats, following the full or partial occlusion of one, two, three, or four cranial neck veins.
[0060] Cranial venous blood flow may be impeded by applying pressure to the tissue overlying the targeted neck vein(s). The pressure may be applied by any suitable device that has the ability, and is configured to, apply a constant or an intermittent pressure to targeted neck veins, wherein the pressure is sufficient impede the flow of venous blood egressing from the cranium. Suitable devices include, for example, a fully-circumferential or partially-circumferential collar described in U.S. Pat. Nos. 9,168,045 and 9,173,660, and patent publications U.S. 2014/0142616, 2014/0343599, WO 2012/054262, WO 2013/055409, and WO 2015/200672, each of which is hereby incorporated by reference in its entirety. Other devices and systems suitable for applying neck vein pressure are disclosed in U.S. Pat. No. 8,900,169 and WO 2014/143853, each of which is hereby incorporated by reference in its entirety.
[0061] Without being bound by any theory, preliminary observations indicate that increasing the cranial venous pressure and/or volume by jugular vein compression has a transient and a permanent effect during the venous compression period. Upon initial internal jugular vein (IJV) compression, it is believed that the cerebral venous blood is diverted from the IJV into the venous capacitance vessels of the cranium and the vertebral venous system. This causes a mass effect or “crowding” of the CSF, resulting in a ventricular constriction and movement of CSF causally and leading to an initial decrease in the uvCSF volume. This observation may result from the fact that the CSF compartment has less resistance to flow than the (venous and arterial) blood compartment. This movement of CSF flow causes a flow of the concentration of somnogenic substances within the uvCSF downward, caudally and out of the cranio-spinal space.
[0062] Following the relative cranial venous blood diversion, a new cranial pressure/volume equilibrium between the blood and CSF compartments is reached. The elevated cranial blood pressure and/or volume caused by persistent occlusion of the jugular vein(s) fills the cranial blood reserve volume and further diminishes the CSF volume. The uvCSF volume therefore is reduced as the uvCSF is pushed into the lower ventricular structures and ultimately in the central canal of the spinal cord. The CSF again flows—in a downward direction—because it has a lower resistance to flow than the venous blood. The second and more persistent equilibrium phase lasts for the duration of the venous compression and is characterized by a reduction in the overall uvCSF volume.
[0063] Accordingly, the fully- or partially-occlusive neck vein pressure may be applied continuously or intermittently/repetitively to improve brain function, depending upon the specific circumstances of the application and the effect that is desired. The continuous application of neck vein pressure (i.e., an indefinite on-time) produces the benefit of reducing the uvCSF concentration of somnogenic substances, and concomitant improvement of brain function, while being relatively easy to administer with the use of a passive device (e.g., a neck collar or other device as described above). Such a device beneficially maintains a smaller uvCSF volume for a prolonged period of time.
[0064] Devices that intermittently and repetitively apply fully- or partially-occlusive neck vein pressure may be useful in applications having a prolonged duration (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 hours, or more), and/or when extremely heightened brain function is desired. Such a device would cycle the occlusive neck vein pressure in an on/off manner, as described below. During each on/off cycle, (i) the uvCSF (high in somnogenic substances) would be mixed with the 1vCSF (low in somnogenic substances) during the first, upward/expansion phase, (ii) the total volume of uvCSF (with a lower somnogenic substance concentration) would be reduced, thereby reducing the total amount of somnogenic substances in the uvCSF compartment, and (iii) mixed again with 1vCSF during the pressure normalization of the uvCSF compartment as the occlusive pressure is removed and reapplied to begin the cycle again.
[0065] As noted above, preliminary studies indicate that cranial blood pressure and/or volume increase within about <0.5-1.0 seconds following jugular vein occlusion; or about the time taken for about 1-2 heartbeats. It is expected that normalization of cranial blood pressure and/or volume following restoration of full venous flow (i.e., removal of the occlusive pressure) takes an approximately equal time. Thus, suitable methods and devices will apply neck vein pressure with an on-time of at least one second (e.g., at least 1, 2, 3, 4, 5, 10, 15, 30, 60, 120, or 180 seconds or more) and/or will have an off-time of at least one second (e.g., at least 1, 2, 3, 4, 5, 10, 15, 30, 60, 120, or 180 seconds or more). It is understood that the on-time and off-time need not have the same duration, and that the on-time and off-time need not be the same in every cycle. It is further understood that the off-time need not return the occlusive neck vein pressure to zero. It is sufficient that the neck vein pressure is reduced during the off-time only to an amount sufficient to cause an increase in the equilibrium uvCSF volume relative to the equilibrium uvCSF volume present during the on-time segment of the cycle.
[0066] Further cycling of the compression from right to left, or left to right, will serve to fill the cranial veins from either the right or the left side and then potentially minimize, or even reverse, the direction of filling from the side being compressed. Then, as that first compression is released and the other side is compressed, a reversal of venous back flow (or reduction as one side of the venous forward flow ensues). The effect would be nearly a “to and fro”, or agitation, of the fluids, allowing for better mixing of volumes of blood or CSF with high concentrations of target substances with volumes of blood or CSF that are lower in concentration.
[0067] Thus, human subjects to which the methods and devices of this invention may be applied include, for example, athletes, soldiers, students, truck and car drivers, railroad engineers, pilots, astronauts, first responders (police, fire, EMTs), medical service providers (nurses and doctors), security guards, and industrial workers. Further, ailments that could be remedied include glaucoma, Meniere's Disease, and any of a number of neurodegenerative disorders such as Alzheimer's or Parkinson's.
[0068] It will be appreciated by persons having ordinary skill in the art that many variations, additions, modifications, and other applications may be made to what has been particularly shown and described herein by way of embodiments, without departing from the spirit or scope of the invention. Therefore, it is intended that scope of the invention, as defined by the claims below, includes all foreseeable variations, additions, modifications or applications.
[0069] The devices disclosed herein are therapeutic in nature and are used to treat maladies or diseases or aging rather than to prevent TBI or force impartations. The devices and methods disclosed herein are not attempting to fill a Compensatory Reserve Volume (CRV) to prevent hydrodynamic energy absorption (SLOSH), but rather are operable to effectuate flow throughout the fluid cranial space to include, but not be limited to, the arteries, veins, interstitial spaces (defining the glymphatic circulatory system), venous capacitance vessels, peri-lymphatic and endo-lymphatic fluids (auditory), ocular fluids (aqueous humor), Cerebrospinal fluids (CSF), and lacrimal fluids (tears). To maximize flow through the systems described above, the present disclosure contemplates compressing/occluding one side of the venous tree accessible by compressing each side of the neck in succession—one side, then the other side—and maintaining a frequency of compression then release to better allow a pumping action to maximize flow, rather than just a “filling” of the venous or CSF spaces. Specifically, in order to treat the conditions contemplated in the present disclosure, it is not beneficial to compress both sides of the venous vasculature tree simultaneously, as this would be like blowing on both ends of a straw which may pressurize or maximally fill an internal space but not create flow. Therefore, the devices and methods disclosed herein are configured and operable to compress or impede flow on one side, release pressure and then compress or impede flow on the other. The devices disclosed herein have the ability to compress just one vessel, or multiple vessels, on one side or the other, but not both sides of the neck at the same time.
[0070] The present disclosure contemplates a compression device 10 having a fitted collar 12 with a compression element 15a, 15b at each end of the collar 12, as shown in
[0071] A drive mechanism 17 is provided the middle of the collar at the back or closed portion of the open-C so that the mechanism is at the back of the neck of the subject. The drive mechanism includes an actuator and a power source that provides power to the actuator. The embodiments of
[0072]
[0073] The drive mechanism 27 is configured to alternately inflate and deflate the bellows structures 26a, 26b of the device to alternately compress or impede venous blood flow on one side of the neck while simultaneously releasing the compression and permitting venous blood flow on the other side of the neck. The drive mechanism can incorporate a valve structure, such as a shuttle valve, between the fluid connections to each bladder structure, along with a controller that controls the valve structure to achieve the alternating pressure and release cycle for each lever 25a, 25b. The controller is configured to repeat the compression/release cycle over and over to effectively “pump” the volumes of venous blood back and forth to allow for better flow, and even turbulence as the venous blood stops and reverse direction as the corresponding side fills and engorges, only to then drain and deflate back and forth. The expanding force applied by each lever needs to be sufficient to overcome an internal pressure of approximately 3-5 mmHg and to overcome the stiffness of the overlying muscles and ligaments and skin. Typically, this force is in the range of 1-5 psi.
[0074] A second compression device 30, shown in
[0075] A third compression device 40, shown in
[0076] The compression device 50 shown in
[0077]
[0078] The compression device 70 in
[0079] In a seventh embodiment, the compression device 80 of
[0080] The compression device 90 shown in
[0081] In a further embodiment, a compression device 100 illustrated in
[0082] The compression devices disclosed herein are configured to alternate compression of vascular structures on opposite sides of a subject's neck to impact the intracranial pressure (ICP), intracranial volume (ICV). In particular, the devices are operable to increased ICP and/or ICV by diverting flow to the venous capacitance vessels of the brain by reducing the jugular venous outflow. Cranial venous flow may be diverted by applying pressure to one or more (e.g., one, two, three, four, or more) neck veins including, for example, the internal jugular vein(s) (“IJVs”) and the external jugular vein(s) (“EJVs”). This flow is then diverted to the venous capacitance vessels and vertebral veins and as the vessels dilate, the cerebral spinous fluid (CSF) equilibrates by circulating down through the interstitial and spinal canal spaces (defining the Glymphatic System). The compression elements, such as elements 25a, 25b of the device 20, for example, are sized and arranged to apply compression to one or more neck veins, depending on the desired treatment protocol.
[0083] The drive mechanisms of the compression devices, such as drive mechanism 27, for example, include a microcontroller, or similar device, that is configured to alternately and intermittently actuate one compression element, while releasing the other compression element to produce cyclic compression and releases. The microcontroller can be configured to apply these cyclic compressions and releases at a predetermined frequency, or at a selectable fast, moderate or slow frequency. In one embodiment, the fastest rate is measured in cycles per minute, the moderate rate is measured in cycles per hour and the slowest in cycles per day. The microcontroller of the drive mechanisms also controls the on-time of each cycle, where the on-time can be measured in seconds or in hours, again depending on the treatment protocol. Similarly, the off-time is controlled by the microcontroller, with off-times also measured in seconds or hours depending on the treatment protocol.
[0084] The drive mechanism and compression elements are configured to generate sufficient pressure against the neck of the subject to substantially occlude the desired venous structure. Thus, the compression devices disclosed herein are configured to generate occlusive pressures ranging from 10 mm Hg to 100 mm Hg.
[0085] The present disclosure provides methods for improving, repairing or preventing impairment of brain function in a subject by facilitating cerebral blood and cerebral spinal fluid flow. The brain function can be selected from the group consisting of arousal, attention or attentiveness, executive functions, learning, memory, motor coordination, spatial awareness, and vigilance. Repairing brain function would relate to improving the above functions after congenital malfunctions (such as hydrocephalus, normal pressure hydrocephalus, Arnold Chiari Malformation (types I, II, and III), spina bifida, syringomyelia, tethered cord syndromes, abnormalities of cortical development (Groups I, II, and III), vascular or cerebrospinal fluid (CSF) compartment abnormalities, or brain injuries. Brain injuries can be traumatic, closed head injuries, acceleration deceleration, contusions, penetrating or shaken baby-type vibrational injury, or acquired injuries or maladies such as toxic or anoxic brain damage (lack of oxygen), infectious or inflammatory conditions (i.e., meningitis or lupus cerebritis), stroke or tumor derived damage or malfunction. Toxic maladies include alcohol, hepatic encephalopathy, Wernicke-Korsakoff, Central Pontine Myelinolysis. Repairing brain function can also be required to address damage caused by any form of dementia such as Alzheimer's, Parkinson's, Pick's, Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease), Vascular, Lewy Body, Frontal-temporal Dementia, Huntington's Disease, Creutzfeldt-Jakob Disease, or Mixed Dementia. The methods are also helpful to improve the above brain function in the setting of aging, ADHD, Post Traumatic Stress Disorder, and other psychiatric disorders such as, but not limited to insomnia, schizophrenia, bipolar disorder, or anxiety disorders. The methods disclosed herein can promote the delivery of endogenous chemicals (oxytocin, vasopressin, anti-diuretic hormone (ADH), or even exogenous chemical delivery such as nutrients, chemotherapy or inti-infectives whether they be anti-viral, anti-bacterial or anti-fungal.
[0086] The present disclosure also provides methods for reducing the concentration of somnogenic substances in the brain of a subject by increasing flow away from the brain and down the spinal cord through the Glymphatic Pathways. The methods include increasing intracranial pressure, blood volume, or both, by administering changes to inspired CO.sub.2 levels by using exogenous or endogenous CO.sub.2 with resultant pushing of CSF flow down from the cerebral compartments into the lower spinal canal and spinal bulb. Exogenous sources of CO.sub.2 can include, but not be limited to, canister or reservoir sources of CO.sub.2, or rebreathing of one's own CO.sub.2 through the addition of various dead space volumes to the respiratory tract or alteration in positive pressure breathing (which alters ventilation).
[0087] In accordance with one feature of the present methods, the intracranial pressure, blood volume, or both can be increased by applying pressure to one or more neck veins, such as the internal jugular veins or at the external jugular veins. The neck vein pressure is about 10 mm Hg to about 100 mm Hg and is applied intermittently in a plurality of cycles, wherein each cycle is characterized as having an on-time having a first neck vein pressure and an off-time having a second neck vein pressure, wherein the first neck vein pressure is greater than the second neck vein pressure. The neck vein pressure is applied alternately to the right then left sides and then back again, at various predetermined frequencies and durations as per below. For example, the on-time can have a duration of 1 second to one hour and the off-time a duration of 1 second to one hour. The first neck vein pressure can be 10-100 mm Hg, while the second neck vein pressure can be 0-50 mm Hg. The intermittent pressure and release is cycled from one side to the other throughout the time period, creating a “to and fro” moving of cranial fluids.